- Collagen Solutions has been awarded a third Medical Research Scotland Ph.D. studentship, this time in partnership with Professor Elizabeth Tanner, of the School of Engineering, at the University of Glasgow.

The project, titled 'Collagen Calcium Phosphate Composite Devices for Bone Augmentation', will investigate the application of collagen fibrils to provide a scaffold for 'critical size defects' in bone, which do not heal spontaneously.

To obtain healing, some form of scaffold or conduit for the bone repair process is essential and this project will aim to develop novel collagen-containing biomaterials to aid the healing process for these larger bone defects. The project is a four-year Ph.D. project expected to start in the next academic year.

Chief executive Jamal Rushdy said: "Our current pipeline includes a novel bone graft substitute product, addressing a segment of the $1.7 billion end-user bone graft market opportunity. This new research programme, funded in collaboration with Medical Research Scotland and Professor Tanner's group within the world-class research facilities at the University of Glasgow, will ensure we continue to innovate in this field. In the future we hope to develop next-generation bone graft substitute technologies, addressing more difficult to heal bone defects, thus ensuring continued scientific leadership in this significant segment of the orthobiologics market."

Currently professor of biomedical materials at the University of Glasgow, Professor Tanner received an OBE for services to biomedical engineering in 2016 and an honorary doctorate within the Faculty of Medicine, Lund University where she is a visiting professor. Her research interests are in the development and use of bioactive materials for bone augmentation and replacement, developing composites of polymers filled with bioactive ceramics based on the mineral phase of bone. One such material developed by her team is HAPEX, used in over half a million patients since 1988. She has published over 150 papers and book chapters and n 2020 she will be president of the 11th World Biomaterials Congress taking place in Glasgow.

Story provided by